Literature DB >> 18603420

RANTES in exhaled breath condensate of stable and unstable asthma patients.

Z Zietkowski1, M M Tomasiak, R Skiepko, A Bodzenta-Lukaszyk.   

Abstract

RANTES has been implicated in the allergic inflammation of asthma by promoting the migration and activation of the inflammatory cells, including eosinophils. The study was undertaken to evaluate RANTES levels in the exhaled breath condensate (EBC) of asthmatics with different degrees of asthma severity. EBC was collected from 33 patients with allergic asthma (11 with steroid-naïve mild asthma, 10 with ICS-treated, stable mild-to-moderate asthma, 12 with ICS-treated unstable, severe asthma) and seven healthy volunteers. In the three groups of asthmatics, RANTES concentrations in EBC were significantly higher compared with healthy volunteers. RANTES levels were significantly higher in patients with unstable asthma than in the two groups with stable disease. We observed statistically significant correlations between the concentrations of RANTES in EBC and F(ENO) in the three studied groups of asthmatics; notably, the correlation between the parameters described above was strong positive in the group of unstable and steroid-naïve stable asthmatics. We also discovered a significantly positive correlation between RANTES in EBC and the serum ECP or blood eosinophil count in the groups of asthmatics with severe, unstable asthma and between RANTES and serum ECP in the group of steroid-naïve stable asthmatics. Measurements of RANTES in EBC may provide another useful diagnostic tool for detecting and monitoring inflammation in patients with asthma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603420     DOI: 10.1016/j.rmed.2008.03.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

Review 1.  Measures of asthma control.

Authors:  Christian Bime; Jessica Nguyen; Robert A Wise
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

Review 2.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

3.  Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Authors:  Ziemowit Zietkowski; Maria M Tomasiak-Lozowska; Roman Skiepko; Elzbieta Zietkowska; Anna Bodzenta-Lukaszyk
Journal:  Respir Res       Date:  2010-08-12

Review 4.  Is the IL-10 promoter polymorphism at position -592 associated with immune system-related diseases?

Authors:  Mojgan Noroozi Karimabad; Mohammad Kazemi Arababadi; Elham Hakimizadeh; Hassan Yousefi Daredori; Mahmood Nazari; Gholamhossein Hassanshahi; Derek Kennedy
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 5.  The potential of biologics for the treatment of asthma.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Rosario Maselli
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

Review 6.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

7.  Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14++CD16+ Peripheral Blood Monocytes of Patients with Severe Asthma.

Authors:  Nami Shrestha Palikhe; Drew Nahirney; Cheryl Laratta; Vivek Dipak Gandhi; Dilini Vethanayagam; Mohit Bhutani; Irvin Mayers; Lisa Cameron; Harissios Vliagoftis
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

8.  Exposure to selected limonene oxidation products: 4-OPA, IPOH, 4-AMCH induces oxidative stress and inflammation in human lung epithelial cell lines.

Authors:  Dorelia Lipsa; Josefa Barrero-Moreno; Mehmet Coelhan
Journal:  Chemosphere       Date:  2017-10-11       Impact factor: 7.086

9.  Presentation, management and mortality after a first MI in people with and without asthma: A study using UK MINAP data.

Authors:  Paulo Pinto; Kieran J Rothnie; Kelvin Lui; Adam Timmis; Liam Smeeth; Jennifer K Quint
Journal:  Chron Respir Dis       Date:  2017-04-10       Impact factor: 2.444

Review 10.  Diagnosis and management of eosinophilic asthma: a US perspective.

Authors:  Hannah H Walford; Taylor A Doherty
Journal:  J Asthma Allergy       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.